Techno Medica Co., Ltd.
6678.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -1.97 | 0.03 | 0.05 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 16.56 | 83.22 | 4.11 | 12.21 |
| Quality | ||||
| ROIC | 1.29% | -0.01% | 3.86% | 1.40% |
| Gross Margin | 48.78% | 46.20% | 48.70% | 50.05% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 0.83% | 1.10% | 1.88% | 3.30% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -29.90 | -183.58 | -12.01 | -29.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.39 | 0.31 | 0.68 | 0.46 |
| Cash Conversion Cycle | 269.89 | 339.89 | 155.22 | 220.27 |